GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Asset Turnover

WPD Pharmaceuticals (XCNQ:WBIO) Asset Turnover : 0.00 (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. WPD Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was C$0.00 Mil. WPD Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 was C$0.28 Mil. Therefore, WPD Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. WPD Pharmaceuticals's annualized ROE % for the quarter that ended in Dec. 2023 was 0.00%. It is also linked to ROA % through Du Pont Formula. WPD Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2023 was 0.00%.


WPD Pharmaceuticals Asset Turnover Historical Data

The historical data trend for WPD Pharmaceuticals's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Asset Turnover Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

WPD Pharmaceuticals Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of WPD Pharmaceuticals's Asset Turnover

For the Biotechnology subindustry, WPD Pharmaceuticals's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WPD Pharmaceuticals's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WPD Pharmaceuticals's Asset Turnover distribution charts can be found below:

* The bar in red indicates where WPD Pharmaceuticals's Asset Turnover falls into.



WPD Pharmaceuticals Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

WPD Pharmaceuticals's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0/( (0.076+0.346)/ 2 )
=0/0.211
=0.00

WPD Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0/( (0.214+0.346)/ 2 )
=0/0.28
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


WPD Pharmaceuticals  (XCNQ:WBIO) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

WPD Pharmaceuticals's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=0/-0.6135
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0 / 0)*(0 / 0.28)*(0.28/ -0.6135)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-0.4564
=ROA %*Equity Multiplier
=0.00 %*-0.4564
=0.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

WPD Pharmaceuticals's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=0/0.28
=(Net Income / Revenue)*(Revenue / Total Assets)
=(0 / 0)*(0 / 0.28)
=Net Margin %*Asset Turnover
= %*0
=0.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


WPD Pharmaceuticals Asset Turnover Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


WPD Pharmaceuticals (XCNQ:WBIO) Business Description

Traded in Other Exchanges
N/A
Address
750 West Pender Street, Suite 401, Vancouver, BC, CAN, V6C 2T7
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, research, and development of medicinal products involving biological compounds and small molecules. The company has eight novel drug candidates which are in clinical development and pre-clinical development stage.

WPD Pharmaceuticals (XCNQ:WBIO) Headlines

No Headlines